← Eichor
Study identifier: NCT06754085 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Condition: Prostate Cancer  ·  Sponsor: HTA Co., Ltd.

PhasePhase 3
Planned participants131
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

In this study, 18F-Florastamin PET/CT will be performed in patients with suspected recurrence of prostate cancer, to assess the diagnostic performance and safety of 18F-Florastamin PET/CT imaging.

This description comes directly from the study's public registry record.

Talk to the study team

Wei Fan  ·  +86 13602883007  ·  fanwei@sysucc.org.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Sun Yat-sen University Cancer CenterGuangzhou, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06754085